Li, X., Cao, L., Yu, Z., He, K., Ding, P., Li, J., . . . Shi, Z. (2024). Dorsomorphin attenuates ABCG2-mediated multidrug resistance in colorectal cancer. Frontiers in pharmacology, 15, 1393693. https://doi.org/10.3389/fphar.2024.1393693
Chicago Style (17th ed.) CitationLi, Xiao-Peng, et al. "Dorsomorphin Attenuates ABCG2-mediated Multidrug Resistance in Colorectal Cancer." Frontiers in Pharmacology 15 (2024): 1393693. https://doi.org/10.3389/fphar.2024.1393693.
MLA (9th ed.) CitationLi, Xiao-Peng, et al. "Dorsomorphin Attenuates ABCG2-mediated Multidrug Resistance in Colorectal Cancer." Frontiers in Pharmacology, vol. 15, 2024, p. 1393693, https://doi.org/10.3389/fphar.2024.1393693.
Warning: These citations may not always be 100% accurate.